Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Journal of Investigative Dermatology Home
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Meeting Abstracts
    • Supplements
  • Authors
    • Back
    • About Open Access
    • Submit a Manuscript 
    • Welcome, Authors!
    • Information for Authors
    • Information for Authors - PDF Download 
    • Contact the Editorial Office
    • Permissions
  • Reviewers
    • Back
    • Information for Reviewers
    • Reviewer Login 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact the Editorial Office
    • Editorial Board
    • Abstracting/Indexing
    • Access Instructions
    • New Content Alerts
    • Submit a Manuscript 
    • Why Publish in JID?
  • Collections
    • Back
    • Atopic Dermatitis
    • Cover Gallery
    • Itch
    • JAAD / JID Junction
    • Landmarks in Cutaneous Biology
    • Melanoma
    • Methods and Techniques for Skin Research
    • Montagna Symposium on the Biology of Skin
    • Pemphigus and Pemphigoid
    • Progress in Translational Research
    • Psoriasis
    • Resources for Clinical Research in the JID
  • News
    • Back
    • Society/Journal News
  • Advertisers 
  • SID
    • Back
    • SID Member Activation 
    • SID Website 
    • Join SID 
    • Annual Meeting 
    • Academic Industry Partnership 
  • ESDR
    • Back
    • ESDR Website 
    • Join ESDR 
    • Awards 
    • Events 
    • Media 
    • Education 
  • JAAD / JID Junction
  • Companion Titles
    • Back
    • Journal of Investigative Dermatology Symposium Proceedings
    • JID Innovations
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
    x

    Filter:

    Filters applied

    • Melanoma
    • Yi, XiuliRemove Yi, Xiuli filter
    Clear all

    Article Type

    • Research Article3

    Publication Date

    Author

    • Gao, Tianwen3
    • Li, Chunying3
    • Wang, Gang3
    • Dai, Wei2
    • Ge, Rui2
    • Guo, Sen2
    • Guo, Weinan2
    • Li, Shuli2
    • Wang, Huina2
    • Yang, Yuqi2
    • Zhang, Weigang2
    • An, Yawen1
    • Chang, Yuqian1
    • Cui, Tingting1
    • He, Yuanmin1
    • Jian, Zhe1
    • Li, Kai1
    • Liu, Lin1
    • Liu, Ling1
    • Luan, Qi1
    • Ma, Jingjing1
    • Shi, Qiong1
    • Song, Pu1
    • Wang, Lin1

    Journal

    • Journal of Investigative Dermatology3

    Keyword

    • siRNA2
    • small interfering RNA2
    • 3,4-dihydro-5-[4-(1-piperidinyl) butoxy]-1(2H)-isoquinolinone1
    • AJCC1
    • American Joint Committee on Cancer1
    • c-Jun amino terminal kinase1
    • CAT1
    • catalase1
    • CI1
    • DPQ1
    • Erk1
    • H2O21
    • HMGB11
    • HR1
    • JNK1
    • LC31
    • MAPK1
    • MC1
    • NER1
    • Nrf21
    • PAR1
    • PARP11
    • ROS1
    • SOD1
    • XPA1

    Access Filter

    • Open Access

    Melanoma

    3 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Original Article Melanocytes/Melanoma
      Open Archive

      Simvastatin Protects Human Melanocytes from H2O2-Induced Oxidative Stress by Activating Nrf2

      Journal of Investigative Dermatology
      Vol. 137Issue 6p1286–1296Published online: February 4, 2017
      • Yuqian Chang
      • Shuli Li
      • Weinan Guo
      • Yuqi Yang
      • Weigang Zhang
      • Qian Zhang
      • and others
      Cited in Scopus: 43
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        The prevention of hydrogen peroxide (H2O2)-induced oxidative stress has proved to be beneficial to vitiligo patients. Simvastatin possesses antioxidative capacity and has shown protective effect in various oxidative stress-related diseases. However, whether simvastatin can protect human melanocytes against oxidative stress has not been investigated. In this study, we initially found that pretreatment with 0.1 μmol/L to 1.0 μmol/L simvastatin led to increased cell viability and decreased cell apoptosis of melanocytes in response to H2O2.
        Simvastatin Protects Human Melanocytes from H2O2-Induced Oxidative Stress by Activating Nrf2
      • Original Article Melanocytes/Melanoma
        Open Archive

        Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1

        Journal of Investigative Dermatology
        Vol. 136Issue 6p1219–1228Published online: February 12, 2016
        • Rui Ge
        • Lin Liu
        • Wei Dai
        • Weigang Zhang
        • Yuqi Yang
        • Huina Wang
        • and others
        Cited in Scopus: 25
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Xeroderma pigmentosum group A (XPA), a key protein in the nucleotide excision repair pathway, has been shown to promote the resistance of tumor cells to chemotherapeutic drugs by facilitating the DNA repair process. However, the role of XPA in the resistance of melanoma to platinum-based drugs like cisplatin is largely unknown. In this study, we initially found that XPA was expressed at higher levels in cisplatin-resistant melanoma cells than in cisplatin-sensitive ones. Furthermore, the knockdown of XPA not only increased cellular apoptosis but also inhibited cisplatin-induced autophagy, which rendered the melanoma cells more sensitive to cisplatin.
          Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1
        • Original Article Melanocytes/Melanoma
          Open Archive

          Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis

          Journal of Investigative Dermatology
          Vol. 136Issue 5p985–993Published online: January 29, 2016
          • Sen Guo
          • Weinan Guo
          • Shuli Li
          • Wei Dai
          • Nan Zhang
          • Tao Zhao
          • and others
          Cited in Scopus: 40
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Melanoma is among the most malignant cancers with notorious aggressiveness, and its prognosis is greatly influenced by progression status. Serum microRNAs are small noncoding RNAs with high stability and easy accessibility in human blood. Their expression profiles are frequently dysregulated in cancers; hence, levels of serum microRNAs may reflect progression status and thus predict melanoma prognosis. In a hospital based case-control study, we found a significant reduction of serum miR-16 level in melanoma patients compared with cancer-free controls (P < 0.001).
            Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis
          Page 1 of 1

          Login to your account

          Show
          Forgot password?
          Don’t have an account?
          Create a Free Account

          If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

          If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

          Cancel
          • Home
          • Articles & Issues
          • Articles In Press
          • Current Issue
          • List of Issues
          • Meeting Abstracts
          • Supplements
          • Authors
          • About Open Access
          • Submit a Manuscript
          • Welcome, Authors!
          • Information for Authors
          • Information for Authors - PDF Download
          • Contact
          • Permissions
          • Reviewers
          • Information for Reviewers
          • Reviewer Login
          • Journal Info
          • About the Journal
          • About Open Access
          • Contact the Editorial Office
          • Editorial Board
          • Abstracting/Indexing
          • Access Instructions
          • New Content Alerts
          • Submit a Manuscript
          • Why Publish in JID?
          • Collections
          • Atopic Dermatitis
          • Cover Gallery
          • Itch
          • JAAD / JID Junction
          • Landmarks in Cutaneous Biology
          • Melanoma
          • Methods and Techniques for Skin Research
          • Montagna Symposium on the Biology of Skin
          • Pemphigus & Pemphigoid
          • Progress in Translational Research
          • Psoriasis
          • Resources for Clinical Research in the JID
          • News
          • Society/Journal News
          • Advertisers
          • SID
          • SID Member Activation
          • SID Website
          • Join SID
          • Annual Meeting
          • Academic Industry Partnership
          • ESDR
          • ESDR Website
          • Join ESDR
          • Awards
          • Events
          • Media
          • Education
          • JAAD / JID Junction - NEW!
          • Companion Titles
          • Journal of Investigative Dermatology Symposium Proceedings
          • JID Innovations
          • Follow Us
          • Facebook
          • Twitter

          The content on this site is intended for healthcare professionals.



          We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
          Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

          • Privacy Policy  
          • Terms and Conditions  
          • Accessibility  
          • Help & Contact

          RELX